Mounjaro Starting Dose
The starting dose of Mounjaro (tirzepatide) is 2.5 mg injected subcutaneously once weekly. 1
Dosing Algorithm
Initial 4 Weeks:
- Start at 2.5 mg subcutaneously once weekly 1
- This dose is specifically for treatment initiation and is not intended for glycemic control 1
- The 2.5 mg starting dose is critical to minimize gastrointestinal adverse reactions 2
After 4 Weeks:
- Increase to 5 mg once weekly 1
Subsequent Dose Escalation (if needed):
- Increase in 2.5 mg increments after at least 4 weeks on the current dose 1
- Titrate monthly based on glycemic control needs and tolerability 2
Maximum Doses:
Critical Administration Details
Timing and Route:
- Administer once weekly, any time of day, with or without meals 1
- Inject subcutaneously in the abdomen, thigh, or upper arm (if administered by another person) 1
- Rotate injection sites with each dose 1
Missed Dose Management:
- If missed, administer within 4 days (96 hours) 1
- If >4 days have passed, skip the missed dose and resume regular schedule 1
- Minimum 3 days (72 hours) must separate doses 1
Important Safety Considerations
Why Start Low: The 2.5 mg starting dose is essential because gastrointestinal side effects (nausea, vomiting, diarrhea) occur most commonly during dose escalation 2. Starting with the lowest dose and using slow dose up-titration is vital for mitigating these adverse effects 2.
Treatment Interruption: If patients discontinue or pause treatment for any length of time, they must restart at the low 2.5 mg dose and titrate up again to allow the body time to acclimate 2.
Real-World Dosing Patterns: In clinical practice, 84.1% of patients initiate at ≤5 mg, and 56.5% remain on doses <10 mg even at their sixth prescription refill, suggesting many patients achieve therapeutic goals without requiring maximum doses 3. Real-world data show that 24 weeks of tirzepatide at a mean dose of 5.32 mg produced weight loss comparable to 72-week trial data 4.